1. Atazanavir/ritonavir-based combination antiretroviral therapy for treatment of HIV-1 infection in adults. (February 2011) Authors: Achenbach, Chad J; Darin, Kristin M; Murphy, Robert L; Katlama, Christine Journal: Future virology Issue: Volume 6:Number 2(2011) Page Start: 157 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Physiologically based pharmacokinetic modelling prediction of the effects of dose adjustment in drug–drug interactions between levonorgestrel contraceptive implants and efavirenz-based ART. (22nd January 2018) Authors: Roberts, Owain; Rajoli, Rajith K R; Back, David J; Owen, Andrew; Darin, Kristin M; Fletcher, Courtney V; Lamorde, Mohammed; Scarsi, Kimberly K; Siccardi, Marco Journal: Journal of antimicrobial chemotherapy Issue: Volume 73:Number 4(2018) Page Start: 1004 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Rifabutin pharmacokinetics and safety among TB/HIV-coinfected children receiving lopinavir/ritonavir-containing second-line ART. (9th December 2020) Authors: Rawizza, Holly E; Oladokun, Regina; Ejeliogu, Emeka; Oguche, Stephen; Ogunbosi, Babatunde O; Agbaji, Oche; Odaibo, Georgina; Imade, Godwin; Olaleye, David; Wiesner, Lubbe; Darin, Kristin M; Okonkwo, Prosper; Kanki, Phyllis J; Scarsi, Kimberly K; McIlleron, Helen M Journal: Journal of antimicrobial chemotherapy Issue: Volume 76:Number 3(2021) Page Start: 710 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗